Skip to main content

Table 3 Relationships between LMR, NLR, PLR and clinicopathologic features of 101 nonelderly patients

From: Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy

Characteristics

Total patients

LMR

NLR

PLR

<4

(n = 43)

≥4

(n = 58)

p value

1.6<

(n = 25)

≥1.6

(n = 76)

p value

147<

(n = 54)

≥147

(n = 47)

p value

Age (years)

 

61.9 ± 5.2

61.6 ± 5.6

0.7778

61.1 ± 5.8

61.9 ± 5.3

0.7249

62.4 ± 5.2

60.8 ± 5.5

0.1294

Gender

   

0.1283

  

0.2392

  

0.1171

 Male

91

41

50

 

21

70

 

51

40

 

 Female

10

2

8

 

4

6

 

3

7

 

WBC

 

6261.2 ± 2234.8

5951.4 ± 1747.8

0.7819

5654.4 ± 1725.4

6224.3 ± 2028.8

0.2101

6242.2 ± 1660.6

5900.6 ± 287.0

0.3863

 Neutrophil

 

4020.2 ± 1757.4

3506.3 ± 1522.4

0.9402

2645.3 ± 978.7

4080.3 ± 1659.8

<0.0001

3481.2 ± 1252.0

4005.4 ± 1969.1

0.109

 Lymphocyte

 

1352.8 ± 621.1

1964.2 ± 584.6

<0.0001

2362.7 ± 651.4

1487.2 ± 520.4

<0.0001

2068.7 ± 601.1

1284.7 ± 473.7

<0.0001

 Monocyte

 

574.3 ± 223.8

336.1 ± 109.6

<0.0001

395.8 ± 163.2

451.3 ± 215.8

0.2417

438.1 ± 172.2

436.9 ± 238.6

0.9756

Platelet

 

230.1 ± 76.1

233.0 ± 70.2

0.8422

215.2 ± 64.4

237.2 ± 74.5

0.9051

205.7 ± 47.3

261.7 ± 84.3

<0.0001

Location of tumor

   

0.0169

  

0.5489

  

0.1445

 Ce

4

4

0

 

0

4

 

0

4

 

 Ut

4

3

1

 

0

4

 

3

1

 

 Mt

49

23

26

 

14

35

 

24

25

 

 Lt

31

11

20

 

8

23

 

19

12

 

 Ae

13

2

11

 

3

10

 

8

5

 

Tumor size (mm)

 

4.9 ± 2.1

3.9 ± 2.8

0.0309

3.4 ± 2.7

4.6 ± 2.5

0.0452

4.0 ± 2.8

4.7 ± 2.2

0.2116

Depth of tumor

   

0.0093

  

0.0018

  

0.0943

 T1a-1b

44

12

32

 

13

31

 

29

15

 

 2

6

1

5

 

5

1

 

4

2

 

 3

40

23

17

 

5

35

 

17

23

 

 4a-4b

11

7

4

 

2

9

 

4

7

 

Lymph node metastasis

   

0.5691

  

0.1307

  

0.3183

 N0

56

22

34

 

18

38

 

32

24

 

 N1

28

13

15

 

6

22

 

16

12

 

 N2

6

4

2

 

1

5

 

3

3

 

 N3

11

4

7

 

0

11

 

3

8

 

Pathological stage

   

0.0003

  

0.0032

  

0.1024

 1a-1b

41

9

32

 

17

24

 

27

14

 

 2a-2b

20

15

5

 

1

19

 

8

12

 

 3a-3c

40

19

21

 

7

33

 

19

21

 

Operation time (min)

 

617.8 ± 142.7

666.4 ± 148.0

0.101

643.33 ± 151.1

646.5 ± 146.8

0.9246

680.2 ± 147.9

606.0 ± 137.2

0.107

Intraoperative blood loss (ml)

 

727.9 ± 578.1

538.5 ± 523.1

0.0543

616.4 ± 567.6

620.1 ± 551.2

0.9772

563.0 ± 531.4

683.7 ± 574.5

0.2753

SCC antigen

 

1.01 ± 0.76

1.20 ± 1.26

0.3828

1.11 ± 1.26

1.11 ± 1.02

0.9667

1.04 ± 0.97

1.20 ± 1.19

0.465

  1. LMR lymphocyte to monocyte ratio, NLR neutrophil to lymphocyte ratio, PLR platelet lymphocyte ratio
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us